Ľudovít Laca, Ivana Dedinská, Ján Janík, Juraj Miklušica, Blažej Palkóci, Michal Hošala
In the last decade, there has been a change in the view on the diagnosis and treatment of benign and malignant liver
tumours. It was caused due to progress in the development of medical techniques as well as enlarged possibilities in
the analysis of the results of the use of new diagnostic imaging methods and therapeutic modalities in large patient series.
Surgery is dominant in the therapy of liver tumours. Mainly in the treatment of malignant tumours it is a method
of choice. The surgical methods include anatomical and non-anatomical resections of the liver, ablation methods, and
their combinations. The goal is to achieve an R0 resection, which means complete tumour removal. Nowadays, in case
of risk of residual hepatic parenchymal insufficiency, the stimulation of the residual liver parenchyma is performed.
Hypertrophy can be maintained with portal vein embolisation and two-stage liver resection – ALPPS and RALPPS.
Other options include liver transplantation and ablation methods.